리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 07월
페이지 정보:영문 203 Pages
라이선스 & 가격 (부가세 별도)
한글목차
컴퓨터 보조 검출(CAD) 시장은 2030년까지 20억 달러에 달할 전망입니다.
2023년에 11억 달러로 평가된 컴퓨터 보조 검출(CAD) 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 9.1%로 성장하고 2030년에는 20억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석 한 부문 중 하나 인 유방 조영술 양식은 복합 연간 성장률(CAGR) 9.8%로 성장을 지속하고, 분석 기간이 끝날 때 7 억 5,900만 달러에 달할 것으로 예측됩니다. MRI 모달리티 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 8.6%로 추정됩니다.
미국 시장은 2억 8,450만 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 12.3%로 성장할 것으로 예측됩니다.
미국의 컴퓨터 보조 검출(CAD) 시장은 2023년 2억 8,450만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 4억 5,800만 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR) 12.3%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR) 각각 5.8%와 7.3%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 약 6.8%로 성장할 것으로 예측됩니다.
세계 컴퓨터 보조 검출(CAD) 시장- 주요 동향과 촉진요인 정리
첨단 알고리즘과 머신러닝을 활용한 CAD(Computer Support Detection) 시스템은 의료 이미지를 해석하고 다양한 의료 분야에서 진단 정확도를 높이는 데 중요한 역할을 합니다. 이 시스템은 X 선, MRI, 내시경, 초음파 등의 이미지에서 잠재적인 이상을 확인하여 방사선과 의사를 지원하고 중요한 진단 지원을 제공합니다. 인공지능과 같은 고급 기술의 통합으로 CAD 시스템은 디지털 병리학, 예방 검진, 긴급 진단 등의 분야에서 점점 더 필수적입니다. 이러한 시스템에 대한 수요 증가는 특히 암과 같은 복잡한 영역에서 조기 발견과 정확한 진단을 지원함으로써 환자의 결과를 개선하는 능력에 의해 야기됩니다.
유방 조영술 및 MRI와 같은 의료 영상 처리 기술의 기술적 진보는 암 유병률 증가와 함께 CAD 시장의 주요 촉진요인이되었습니다. 이러한 개선으로 보다 정밀하고 고해상도의 이미지를 얻을 수 있게 되어 CAD 소프트웨어가 보다 정확한 분석을 할 수 있게 되었습니다. 또한, 의료 관리를 클라우드 컴퓨팅으로 전환하면 IT 비용 절감과 의료 종사자 간의 협업 강화를 제공하는 확장 가능하고 액세스 가능한 CAD 솔루션을 개발할 수 있습니다. 다양한 진단 장비의 이미지를 분석 할 수있는 다중 모드 CAD 시스템의 동향은 진단 정확도와 환자 결과를 더욱 향상시킵니다.
CAD 시스템의 AI 통합은 방대한 데이터 세트에서 학습하고 암과 같은 질병을 나타내는 복잡한 패턴과 이상을 인식하는 도구를 제공함으로써 의료 영상 진단에서 중요한 진화를 의미합니다. 이 AI 통합은 진단을 가속화하고, 휴먼 오류를 줄이고, 예방 건강 관리 및 조기 진단에 중점을 둡니다. 일반적인 영상 진단에 그치지 않고 CAD 시스템은 대장 내시경 검사의 폴립과 호흡기 내과의 폐 결절과 같은 질병의 검출에 특화된 용도도 발견하고 있습니다. 현재 진행중인 조사에서는 CAD의 혁신은 디지털 병리학에도 진출하고 있으며, 면역 염색뿐만 아니라 표준 H&E 염색 분석 등 보다 광범위한 진단 작업에의 응용이 확대되고 있습니다.
조사 대상 기업 예(전 103사)
Agfa-Gevaert NV
FUJIFILM Holdings Corporation
GE Healthcare
Hitachi Ltd.
Hologic, Inc.
iCAD, Inc.
Invivo Corporation
Koninklijke Philips NV
McKesson Corporation
Merge Healthcare, Inc.
Siemens Healthineers
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
BJH
영문 목차
영문목차
Global Computer Aided Detection (CAD) Market to Reach US$2.0 Billion by 2030
The global market for Computer Aided Detection (CAD) estimated at US$1.1 Billion in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. Mammography Modality, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$759.0 Million by the end of the analysis period. Growth in the MRI Modality segment is estimated at 8.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$284.5 Million While China is Forecast to Grow at 12.3% CAGR
The Computer Aided Detection (CAD) market in the U.S. is estimated at US$284.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$458.0 Million by the year 2030 trailing a CAGR of 12.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.
Global Computer Aided Detection (CAD) Market - Key Trends and Drivers Summarized
Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.
Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.
The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.
Select Competitors (Total 103 Featured) -
Agfa-Gevaert NV
FUJIFILM Holdings Corporation
GE Healthcare
Hitachi Ltd.
Hologic, Inc.
iCAD, Inc.
Invivo Corporation
Koninklijke Philips NV
McKesson Corporation
Merge Healthcare, Inc.
Siemens Healthineers
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Computer Aided Detection (CAD) - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Prevalence of Cancer Drives Computer Aided Detection Market Growth
Need for Early Disease Detection Spur Adoption of CAD
Integration of AI and Machine Learning in CAD Systems Throws Spotlight on Innovation
Expansion of Telemedicine and Remote Diagnostics Accelerates Market Growth
Increasing Demand for Automated Detection Solutions Drives Market Demand
Rising Investments in Cancer Research Expands Market Horizons
Growing Focus on Reducing Diagnostic Errors Spurs Adoption of CAD Systems
Increasing Use of CAD in Breast Cancer Screening Sustains Market Growth
Rising Demand for CAD in Lung Cancer Detection Here is the Story
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Cardiovascular & Neurological Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Cardiovascular & Neurological Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Cardiovascular & Neurological Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Ultrasound Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Ultrasound Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Ultrasound Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Tomosynthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Tomosynthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Tomosynthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Other Imaging Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Computer Aided Detection (CAD) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 26: World Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
CANADA
TABLE 35: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
JAPAN
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
CHINA
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 47: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
EUROPE
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 53: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 62: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 65: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
GERMANY
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 68: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 71: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 77: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
UNITED KINGDOM
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 80: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 83: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
SPAIN
TABLE 86: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Spain Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Spain 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 89: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Spain Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Spain 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
RUSSIA
TABLE 92: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Russia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Russia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 95: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Russia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Russia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of Europe 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of Europe 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 113: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Australia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Australia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 116: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Australia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Australia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
INDIA
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 119: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: India Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: India 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 122: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: India Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: India 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 125: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: South Korea Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: South Korea 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 128: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: South Korea Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: South Korea 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
LATIN AMERICA
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 137: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 140: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Latin America Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
TABLE 143: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 144: Latin America Historic Review for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
ARGENTINA
TABLE 146: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Argentina Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Argentina 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 149: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Argentina Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Argentina 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
BRAZIL
TABLE 152: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Brazil Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Brazil 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 155: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Brazil Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Brazil 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
MEXICO
TABLE 158: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Mexico Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Mexico 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 161: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Mexico Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Mexico 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Rest of Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Rest of Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
MIDDLE EAST
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 170: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 173: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Middle East Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
TABLE 176: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
IRAN
TABLE 179: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Iran Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Iran 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 182: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Iran Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Iran 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
ISRAEL
TABLE 185: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Israel Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Israel 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 188: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Israel Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Israel 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Saudi Arabia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Saudi Arabia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 197: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: UAE Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: UAE 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 200: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: UAE Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: UAE 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Rest of Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Rest of Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
AFRICA
Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 209: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Africa Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Africa 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
TABLE 212: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Africa Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Africa 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030